Ardelyx Inc (ARDX)

Currency in USD
3.960
-0.040(-1.00%)
Real-time Data·
ARDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.9604.090
52 wk Range
3.9008.400
Key Statistics
Prev. Close
4
Open
4.02
Day's Range
3.96-4.09
52 wk Range
3.9-8.4
Volume
6.14M
Average Volume (3m)
3.94M
1-Year Change
-26.5741%
Book Value / Share
0.6
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ARDX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.000
Upside
+228.28%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Ardelyx Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

11 Buy
0 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 13.000
(+228.28% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
TD Cowen
Buy10.00+152.21%13.00Maintain07/08/2026
Ladenburg Thalmann
Buy16.00+303.53%-New Coverage16/06/2026
Leerink Partners
Buy17.00+328.75%-Maintain12/03/2026
Piper Sandler
Buy16.00+303.53%-Maintain23/02/2026
H.C. Wainwright
Buy18.00+353.97%10.00Maintain20/02/2026

Ardelyx Inc Earnings Call Summary for Q2/2026

  • Q2 revenue hit record $118M, up 31% YoY, but missed estimates of $125M; IBSRELA rose 33% to $86.2M, XPHOZAH up 27% to $31.9M amid payer headwinds.
  • Ardelyx cut IBSRELA 2026 guidance to $350M-$370M and withdrew XPHOZAH's $750M target, citing reimbursement uncertainty and tighter prior authorization rules.
  • Net loss narrowed to $16.7M from $19.1M YoY; operating expenses revised below $500M for 2026, with profitability still expected in 2027 despite access challenges.
  • Stock plunged 18% to $3.99 in after-hours trading, falling below 52-week low of $4.71 as investors reacted negatively to reduced outlook and withdrawn guidance.
  • Management cited payer restrictions as key challenge but maintained IBSRELA's $1B revenue path; ACCEL Phase III trial for CIC indication remains on track with data in ~1 year.
Last Updated: 07/08/2026, 07:16 am
Read Full Transcript

Earnings

Latest Release
06/08/2026
EPS / Forecast
-0.07 / -0.03
Revenue / Forecast
118.1M / 125.68M
EPS Revisions
Last 90 days

ARDX Income Statement

Compare ARDX to Peers and Sector

Metrics to compare
ARDX
Peers
Sector
Relationship
P/E Ratio
−17.9x−4.2x−0.4x
PEG Ratio
−4.47−0.080.00
Price/Book
6.7x1.5x2.6x
Price / LTM Sales
2.2x2.4x3.1x
Upside (Analyst Target)
237.5%58.9%48.2%
Fair Value Upside
Unlock17.4%5.8%Unlock

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
71.65M29.00%286.58M
Other Institutional Investors
122.00M49.39%487.98M
Public Companies & Retail Investors
53.39M21.61%213.55M
Total
247.03M100.00%988.12M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.57%21,164,13284,657
Millennium Management LLC7.22%17,842,37071,369

People Also Watch

11.385
HLIT
-1.85%
5.730
SATL
+7.50%
21.83
LEGN
+5.66%
49.61
VECO
+0.55%

FAQ

What Is the Ardelyx Inc (ARDX) Stock Price Today?

The Ardelyx Inc stock price today is 3.960 USD.

What Stock Exchange Does Ardelyx Inc Trade On?

Ardelyx Inc is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Ardelyx Inc?

The stock symbol for Ardelyx Inc is "ARDX."

What Is the Ardelyx Inc Market Cap?

As of today, Ardelyx Inc market cap is 993.010M USD.

What Is Ardelyx Inc's Earnings Per Share (TTM)?

The Ardelyx Inc EPS (TTM) is -0.228.

When Is the Next Ardelyx Inc Earnings Date?

Ardelyx Inc will release its next earnings report on 29/10/2026.

From a Technical Analysis Perspective, Is ARDX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Ardelyx Inc Stock Split?

Ardelyx Inc has split 0 times.

How Many Employees Does Ardelyx Inc Have?

Ardelyx Inc has 489 employees.

What is the current trading status of Ardelyx Inc (ARDX)?

As of 11/08/2026, Ardelyx Inc (ARDX) is trading at a price of 3.960 USD, with a previous close of 4.000 USD. The stock has fluctuated within a day range of 3.960 USD to 4.090 USD, while its 52-week range spans from 3.900 USD to 8.400 USD.

What Is Ardelyx Inc (ARDX) Price Target According to Analysts?

The average 12-month price target for Ardelyx Inc is 13.000 USD, with a high estimate of 18 USD and a low estimate of 8 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +228.28% Upside potential.

What Is the ARDX Premarket Price?

ARDX's last pre-market stock price is 4.040 USD. The pre-market share volume is 3,990.000, and the stock has decreased by 0.040, or 1.000%.

What Is the ARDX After Hours Price?

ARDX's last after hours stock price is 4.000 USD, the stock has decreased by 0.005, or 0.130%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.